CIK: 1314703 - Address: 950 Tower Lane, Suite 700, Foster City, CA 94404
7 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret117-2-4-5-22-46-68-25
S%wins100100100100100100100

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

11/21/07 17:51
11/21/07
OREXOrexigen Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsScale Venture Partners Ii, LPCATS-215.000002,717D-187-162-1-400-2-21-47-61
11/20/07 20:15
11/19/07
OREXOrexigen Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsScale Venture Partners Ii, LPCATS.m-4215.020-302,718D-174-1830-7-3-4-4-22-49-70
11/19/07 21:22
11/16/07
OREXOrexigen Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsScale Venture Partners Ii, LPCATS-25115.530-16-12,720D-33-1263-20-3-4-20-45-68
11/19/07 21:21
11/16/07
OREXOrexigen Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsScale Venture Partners Ii, LPCATS-47615.660-30-12,736D-33-1263-20-3-4-20-45-68
11/16/07 17:03
11/15/07
OREXOrexigen Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsScale Venture Partners Ii, LPCATS-2315.580-102,767D-1-1-11536-4-7-8-24-46-69
11/16/07 17:03
11/15/07
OREXOrexigen Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsScale Venture Partners Ii, LPCATS-22115.590-14-12,768D-1-1-11536-4-7-8-24-46-69
11/16/07 17:02
11/14/07
OREXOrexigen Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsScale Venture Partners Ii, LPCATS.m-23015.540-15-12,783D-1-1-11536-4-7-8-24-46-69

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact